Using the immune system to fight the deadly disease shows promise, executives say, but vaccines may take years to bring to market.
FIGHTING THE GOOD FIGHT: A technician from Cytel, one of the many immunotherapeutic biotech firms, works on developing a cancer vaccine.
Dozens of biotech firms are researching and...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!